Anatomic Pathology Market
Number of pages: 100 | Report Format: PDF | Published date: March 06, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 19.09 billion |
|
Revenue Forecast in 2031 |
US$ 35.53 billion |
|
CAGR |
7.3% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product And Services, Application, End-User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global anatomic pathology market was valued at US$ 19.09 billion in 2022 and is expected to register a revenue CAGR of 7.3% to reach US$ 35.53 billion by 2031.
Anatomic Pathology Market Fundamentals
Anatomic pathology is a branch of pathology that focuses on studying the structure and function of organs, tissues, and cells. Anatomic pathology involves the examination of biopsy and surgical specimens to diagnose diseases and determine the extent and nature of the disease in patients.
Anatomic pathology can be divided into several sub-specialties, including surgical pathology, which includes the examination of tissues removed during surgery to diagnose diseases, such as cancer. Cytopathology is the study of cells obtained from various body sites, such as the cervix, breast, or lungs, to diagnose diseases such as cancer. Autopsy pathology includes the examination of organs and tissues after death to determine the cause of death and identify any underlying diseases or conditions. Neuropathology is the study of diseases of the nervous system, including the brain and spinal cord. Dermatopathology includes the study of diseases of the skin. Anatomic pathologists use various techniques and tools to examine tissues and cells, including microscopy, immunohistochemistry, molecular diagnostics, and electron microscopy. The findings are used to diagnose and guide treatment decisions for patients.
[5765767]
Anatomic Pathology Market Dynamics
The increasing prevalence of cancer and other chronic diseases globally is the major factor propelling the revenue growth of the anatomic pathology market. Moreover, the rise in the adoption of advanced technologies such as AI in pathology lab equipment, including gross imaging and digital microscopes, is also boosting the revenue growth of the global market. The rise in the use of biomarkers in pathology for the diagnosis of cancers is also increasing the demand for anatomic pathology. Additionally, the growing demand for the early detection of diseases and increasing focus on precision medicine are propelling the revenue growth of the global market. Similarly, the usage of digital imaging provides accurate and targeted information. Moreover, a good reimbursement policy is fueling revenue growth in the global market. The robust drug pipeline for cancer is also increasing the usage of anatomic pathology, and continuous launch of and innovation in the pathology equipment are expected to help in the expansion of the global market.
However, anatomic pathology tests and services can be expensive, particularly for advanced tests that require specialized equipment and expertise. This may limit the adoption of these tests and services, particularly in developing countries and among low-income populations. Reimbursement for anatomic pathology tests and services can be challenging, particularly in countries with complex healthcare systems. This could limit the availability of these tests and services, specifically in the public sector. Anatomic pathology requires skilled professionals with specialized training and expertise. A shortage of such professionals may limit the availability of these tests and services, remarkably in developing countries. Compliance with regulations and guidelines can be challenging for anatomic pathology laboratories, particularly in countries with complex regulatory systems. This could impact the availability and quality of these tests and services. Alternative diagnostic methods, such as liquid biopsy and imaging tests, are increasingly used to diagnose diseases. This is expected to limit the demand for anatomic pathology tests and services in some cases.
Anatomic Pathology Market Ecosystem
The global anatomic pathology market has been analyzed from four perspectives: product and services, application, end-user, and region.
Anatomic Pathology Market by Product and Services
[85675]
Based on product and services, the global anatomic pathology market has been segmented into consumables, services, and instruments.
The consumable segments accounted for the largest market revenue share in 2022. The consumable segment is further sub-segmented into reagents & antibodies, probes & kits, and other consumables. The large revenue share of the segment can be attributed to the low cost and increased demand for consumables in pathology labs. Moreover, there is a great rise in the demand for reagents and kits in R&D, and testing of novel drugs is also playing a significant role in segment revenue growth. The major companies are also continuously developing new products, further boosting the segment revenue growth. The increase in the demand for primary and secondary antibodies in detection, sorting, or purification in pathology is also fueling segment revenue growth.
Anatomic Pathology Market by Application
Based on application, the global anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and others.
The diseases diagnosis segment dominated the global anatomic pathology market with the largest market revenue share in 2022. The rise in the demand for early detection of chronic diseases such as cancer is boosting segment revenue growth. Furthermore, anatomic pathology aids the research to study the disease cause, and thus there is a rise in the application of anatomic pathology. Moreover, the growing geriatric population is more prone to chronic diseases; thus, the demand for disease diagnosis has increased. A continuous launch of innovation in new diagnosis methods is also propelling segmental revenue growth.
Anatomic Pathology Market by End-user
Based on end-user, the global anatomic pathology market is segmented into hospitals, research laboratories, and diagnostic laboratories.
The hospitals segment accounted for the largest revenue share of the global anatomic pathology market in 2022. This can be attributed to the presence of large patient footfall in hospitals. Furthermore, the presence of in-house diagnosis services with the rise in cancer patients is propelling segment revenue growth. The presence of well-developed infrastructure with experienced hospital professionals is augmenting segment revenue growth.
Anatomic Pathology Market by Region
Based on region, the global anatomic pathology market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America dominated the global anatomic pathology market, followed by Europe in 2022. Asia Pacific is the fastest-growing regional market. The rise in the prevalence of chronic diseases and the increase in the geriatric population are propelling regional revenue growth. Moreover, well-developed healthcare infrastructure and the rise in healthcare expenditure in the region are boosting regional revenue growth. Similarly, favorable reimbursement policies and the presence of major players in the region are expanding regional revenue development. A rise in the demand for early diagnosis of diseases and an increase in initiatives by government organizations in the region to spread awareness regarding early diagnosis are fueling regional revenue growth.
Anatomic Pathology Market Competitive Landscape
The prominent players operating in the global anatomic pathology market are:
Anatomic Pathology Market Strategic Developments
The global anatomic pathology market is expected to be valued at US$ 35.53 billion by 2031.
Regionally, North America accounts for the largest market revenue share, followed by Europe; Asia Pacific is expected to be the fastest-growing region during the forecast period.
F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, and Agilent Technologies are among the top market players.
The diseases diagnosis segment dominates the global anatomic pathology market.
High costs, reimbursement challenges, lack of skilled professionals, and regulatory hurdles are restraining factors in the market.
*Insights on financial performance are subject to the availability of information in the public domain